FLEXamers: A Double Tag for Universal Generation of Versatile Peptide-MHC Multimers.


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
01 04 2019
Historique:
received: 25 10 2018
accepted: 25 01 2019
pubmed: 15 2 2019
medline: 10 1 2020
entrez: 15 2 2019
Statut: ppublish

Résumé

Peptide-MHC (pMHC) multimers have become a valuable tool for immunological research, clinical immune monitoring, and immunotherapeutic applications. Biotinylated tetramers, reversible Streptamers, or dye-conjugated pMHC multimers are distinct pMHC reagents tailored for T cell identification, traceless T cell isolation, or TCR characterization, respectively. The specific applicability of each pMHC-based reagent is made possible either through conjugation of probes or reversible multimerization in separate production processes, which is laborious, time-consuming, and prone to variability between the different types of pMHC reagents. This prohibits broad implementation of different types of pMHC reagents as a standard toolbox in routine clinical immune monitoring and immunotherapy. In this article, we describe a novel method for fast and standardized generation of any pMHC multimer reagent from a single precursor ("FLEXamer"). FLEXamers unite reversible multimerization and versatile probe conjugation through a novel double tag (Strep-tag for reversibility and Tub-tag for versatile probe conjugation). We demonstrate that FLEXamers can substitute conventional pMHC reagents in all state-of-the-art applications, considerably accelerating and standardizing production without sacrificing functional performance. Although FLEXamers significantly aid the applicability of pMHC-based reagents in routine workflows, the double tag also provides a universal tool for the investigation of transient molecular interactions in general.

Identifiants

pubmed: 30760621
pii: jimmunol.1801435
doi: 10.4049/jimmunol.1801435
doi:

Substances chimiques

Histocompatibility Antigens 0
Receptors, Antigen, T-Cell 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2164-2171

Informations de copyright

Copyright © 2019 by The American Association of Immunologists, Inc.

Auteurs

Manuel Effenberger (M)

Institute for Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, 81675 Munich, Germany.

Andreas Stengl (A)

Department of Biology II, Ludwig Maximilian University of Munich, 82152 Planegg-Martinsried, Germany.

Kilian Schober (K)

Institute for Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, 81675 Munich, Germany.

Maria Gerget (M)

Institute for Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, 81675 Munich, Germany.

Maximilian Kampick (M)

Institute for Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, 81675 Munich, Germany.

Thomas R Müller (TR)

Institute for Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, 81675 Munich, Germany.
National Center for Infection Research, 85748 Munich, Germany; and.

Dominik Schumacher (D)

Department of Biology II, Ludwig Maximilian University of Munich, 82152 Planegg-Martinsried, Germany.

Jonas Helma (J)

Department of Biology II, Ludwig Maximilian University of Munich, 82152 Planegg-Martinsried, Germany.

Heinrich Leonhardt (H)

Department of Biology II, Ludwig Maximilian University of Munich, 82152 Planegg-Martinsried, Germany.

Dirk H Busch (DH)

Institute for Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, 81675 Munich, Germany; dirk.busch@tum.de.
National Center for Infection Research, 85748 Munich, Germany; and.
Clinical Cell Processing and Purification Focus Group, Institute for Advanced Study, Technical University of Munich, 81675 Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH